|
|
Volumn 22, Issue 5, 2007, Pages 358-366
|
|
Pharmacokinetics of aripiprazole, a new antipsychotic, following oral dosing in healthy adult Japanese volunteers: influence of CYP2D6 polymorphism.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ARIPIPRAZOLE;
CYTOCHROME P450 2D6;
NEUROLEPTIC AGENT;
OPC 14857;
OPC-14857;
PIPERAZINE DERIVATIVE;
QUINOLONE DERIVATIVE;
UNCLASSIFIED DRUG;
ADULT;
ARTICLE;
ASIAN;
BIOTRANSFORMATION;
BLOOD;
CLINICAL TRIAL;
DRUG ADMINISTRATION;
GENETIC POLYMORPHISM;
GENETICS;
HOMOZYGOTE;
HUMAN;
JAPAN;
METABOLISM;
ORAL DRUG ADMINISTRATION;
PHENOTYPE;
REFERENCE VALUE;
TABLET;
ADMINISTRATION, ORAL;
ADULT;
ANTIPSYCHOTIC AGENTS;
ASIAN CONTINENTAL ANCESTRY GROUP;
BIOTRANSFORMATION;
CYTOCHROME P-450 CYP2D6;
DRUG ADMINISTRATION SCHEDULE;
HOMOZYGOTE;
HUMANS;
JAPAN;
PHENOTYPE;
PIPERAZINES;
POLYMORPHISM, GENETIC;
QUINOLONES;
REFERENCE VALUES;
TABLETS;
|
|
EID: 38449084441
PISSN: 13474367
EISSN: None
Source Type: Journal
DOI: 10.2133/dmpk.22.358 Document Type: Article |
|
Times cited : (71)
|
|
References (0)
|
